...
首页> 外文期刊>Internal medicine. >Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor
【24h】

Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor

机译:从胸腔积液诊断为小细胞癌成分并从肿瘤诊断为鳞状细胞癌的肺癌

获取原文

摘要

There have been few reports on the accuracy of the diagnosis of small-cell carcinoma based on a cytological examination of malignant pleural effusion, so whether or not such a diagnosis is possible using this approach alone remains unclear. We herein report a 76-year-old Japanese man in whom small-cell carcinoma was diagnosed cytopathologically from pleural effusion and squamous cell carcinoma was diagnosed histopathologically from a transbronchial biopsy. Tumor shrinkage was achieved by treatment with docetaxel, but the efficacy of carboplatin plus etoposide was inadequate. If small-cell carcinoma is detected on the basis of pleural fluid cytopathology alone, it is extremely important to perform a histopathological examination to rule out the possibility of other malignancies.
机译:很少有基于恶性胸腔积液的细胞学检查诊断小细胞癌的准确性的报道,因此仅使用这种方法是否可以进行这种诊断尚不清楚。我们在这里报告了一个76岁的日本男子,其中从胸腔积液的细胞病理学诊断为小细胞癌,而从经支气管活检的病理学诊断为鳞状细胞癌。通过多西他赛治疗可达到肿瘤缩小,但卡铂加依托泊苷的疗效不足。如果仅凭胸水细胞病理学检查出小细胞癌,则进行组织病理学检查以排除其他恶性肿瘤的可能性非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号